Clearstead Trust’s Alkermes ALKS Stock Holding History

Clearstead Trust’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-69	Closed	-$2.07K	–	1029
2025 Q3	$2.07K	Hold	69	–	–	﹤0.01%	982
2025 Q2	$1.98K	Buy	+69	New	+$2.05K	﹤0.01%	961

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clearstead Trust's ALKS Position: Q4 2025 in Review

Clearstead Trust sold out of Alkermes (ALKS) in Q4 2025, closing a stake of 69 shares — an estimated $2.07K sold.

Clearstead Trust first reported a position in ALKS in Q2 2025 and held it in 2 quarters. The position peaked at $2.07K in Q3 2025. 366 funds tracked by Wall St. Rank hold ALKS as of Q4 2025.

Clearstead Trust reported no remaining Alkermes position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 69 Alkermes shares in Q4 2025, an estimated $2.07K.
Clearstead Trust first reported a position in Alkermes in Q2 2025 and held it in 2 quarters.
Clearstead Trust's Alkermes position peaked at $2.07K in Q3 2025.
366 funds tracked by Wall St. Rank held Alkermes as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.